L’évaluation gériatrique et les scores pronostiques chez le patient âgé atteint de cancer : une aide à la décision thérapeutique ?

Two-thirds of newly diagnosed cancers occur in individuals over 65 years old.

• Older cancer patients are often excluded from clinical trials, complicating treatment extrapolation.
• A comprehensive geriatric assessment (CGA) is recommended for patients aged 70 and over to identify vulnerabilities.
• The CGA evaluates various factors such as comorbidities, polypharmacy, and mobility, which may be linked to adverse outcomes.
• No validated algorithms exist to guide therapeutic decisions in geriatric oncology based on CGA findings.
• Collaboration between geriatricians and oncologists is important for developing suitable treatment strategies.

AI simplified